E. Bichisao

Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

Emilio Bajetta, Laura Catena, Giuseppe Procopio et al. · Cancer Chemotherapy and Pharmacology · 2006 · 241 citations

Oncology, Medicine, Are Capecitabine +7

Age and blood pressure changes. A 20-year follow-up study in nuns in a secluded order.

Mario Timio, Paolo Verdecchia, Sandro Venanzi et al. · Hypertension · 1988 · 165 citations

Nursing, Family Medicine, Hypertension +15

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial

Luigi Celio, S. Frustaci, Angela Denaro et al. · Supportive Care in Cancer · 2010 · 100 citations · Full text

Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?

Emilio Bajetta, Laura Catena, Giuseppe Procopio et al. · Annals of Oncology · 2005 · 76 citations · Full text

Neuroendocrine Tumours, Urology, Appropriate Treatment +10

Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients1Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Angeles, U.S.A.1

Emilio Bajetta, Nicoletta Zilembo, Mitch Dowsett et al. · European Journal of Cancer · 1999 · 69 citations

Endocrine Oncology, Breast Oncology, May 1998 +15